ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
136.74
-5.72 (-4.02%)
Mar 5, 2026, 4:00 PM EST - Market closed
ICU Medical Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$182.25
Upside
+33.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $175 → $180 | Buy | Maintains | $175 → $180 | +31.64% | Feb 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $172 → $178 | Buy | Maintains | $172 → $178 | +30.17% | Feb 20, 2026 |
| Keybanc | Keybanc | Buy Maintains $173 → $175 | Buy | Maintains | $173 → $175 | +27.98% | Nov 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $153 → $172 | Buy | Maintains | $153 → $172 | +25.79% | Nov 7, 2025 |
| Keybanc | Keybanc | Buy Maintains $191 → $173 | Buy | Maintains | $191 → $173 | +26.52% | Oct 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $145 → $153 | Buy | Maintains | $145 → $153 | +11.89% | Sep 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $145 | Buy | Initiates | $145 | +6.04% | Aug 15, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $187 → $180 | Strong Buy | Maintains | $187 → $180 | +31.64% | Aug 8, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $197 → $187 | Strong Buy | Maintains | $197 → $187 | +36.76% | May 9, 2025 |
| Keybanc | Keybanc | Buy Maintains $209 → $191 | Buy | Maintains | $209 → $191 | +39.68% | Apr 21, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 8, 2025 |
| Raymond James | Raymond James | Buy → Strong Buy Maintains $205 → $197 | Buy → Strong Buy | Maintains | $205 → $197 | +44.07% | Mar 12, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $200 | Hold → Strong Buy | Upgrades | $200 | +46.26% | Dec 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $198 → $209 | Buy | Maintains | $198 → $209 | +52.84% | Nov 13, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| Keybanc | Keybanc | Buy Maintains $147 → $198 | Buy | Maintains | $147 → $198 | +44.80% | Oct 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.